Swiss economy could lose more than $100 billion due to fallout of coronavirus pandemic, says govt
A government economist said the impact of the coronavirus on Switzerland’s export-orientated economy could take longer to be fully overcome, as unemployment rises and trade stutters due to a slowdown in other countries.
Zurich: Switzerland’s economy could lose more than USD 100 billion in output due to the fallout from the coronavirus pandemic, the government said on Tuesday.
The government expects 2020 gross domestic product (GDP) to be around 652 billion Swiss francs (USD 687.26 billion), down from its December forecast for 712 billion francs. For 2021 it now expects a figure of 688 billion francs, down from the previous view of 725 billion francs.
“On a per capita basis the downturn is going to be as bad as the mid-1970s, if not worse,” said government economist Ronald Indergand. “It is going to take years to get over this. The economy is only going to get back to its previous level by 2022.”
He was speaking after the State Secretariat for Economic Affairs forecast a 6.2 percent decline for the economy during 2020, before a moderate recovery in 2021.
Follow latest updates on coronavirus outbreak here
Indergand said the impact of the coronavirus on Switzerland’s export-orientated economy could take longer to be fully overcome, as unemployment rises and trade stutters due to a slowdown in other countries.
“Government debt will rise, and company and household debt will also rise which might reduce spending and economic growth,” he told Reuters.
“There is still also the risk of a second wave of COVID-19, and how this can be contained. This could have very negative consequences for the economy and significantly slow the recovery,” he added.
On this day: Important events that happened on 11 March in the past
The World Health Organization (WHO) had declared on 11 March 2020 that the COVID-19 outbreak was a pandemic
This is why Beijing's population has declined for 1st time in 2 decades
Beijing's population decline was in line with national trends, with China's population falling last year for the first time in six decades
COVID-19 pill Paxlovid moves closer to full FDA approval
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021. The agency has the final say on giving Pfizer's drug full approval and is expected to decide by May.